Secondary care management of patients with hidradenitis suppurativa in the United Kingdom and Ireland: a survey of current practice

Wainman, Hannah E. and Ingram, John R. ORCID: https://orcid.org/0000-0002-5257-1142 2026. Secondary care management of patients with hidradenitis suppurativa in the United Kingdom and Ireland: a survey of current practice. Clinical and Experimental Dermatology , llag132. 10.1093/ced/llag132

PDF - Accepted Post-Print Version Available under License Creative Commons Attribution. Download (773kB)

Abstract

Background Despite therapeutic advances for hidradenitis suppurativa (HS), specialist multidisciplinary services remain limited. The UK and Ireland HS Network (H-SKIN) seeks to advance evidence-based management and optimise outcomes through collaborative clinical practice. Objectives This study examined variations in management and access to treatment between specialist and non-specialist services. Methods An online survey open from April to August 2025 explored clinical practice in HS management. It was distributed via H-SKIN, the British Association of Dermatologists (BAD) and the British Dermatology Nursing Group (BDNG) networks. Results The survey received 99 responses (38 H-SKIN; 61 BAD/BDNG). Medication use varied, with the biggest differences in metformin (89% H-SKIN; 62% BAD/BDNG), secukinumab (92% H-SKIN; 52% BAD/BDNG) and spironolactone (71% H-SKIN; 46% BAD/BDNG). Deroofing and wide local excision were available to 42% and 84% respectively, of the H-SKIN group compared to 23% and 70% in the BAD/BDNG group. Pain scores were recorded more often in the H-SKIN group (61% versus 32%). Mental health screening was conducted by 89% of the H-SKIN group and 69% of the BAD/BDNG group. Psychological support was available to 37% of the H-SKIN group compared to 8% of the BAD/BDNG group. In the BAD/BDNG group 79% had no access to a Multidisciplinary Team (MDT) to discuss HS patients. Conclusion The results highlight UK disparities in access to HS medical therapies, deroofing and MDT support. Improvements in the standardisation of care are needed. The new National HS MDT run by H-SKIN will help to facilitate this by improving access to specialist support.

Item Type:	Article
Date Type:	Published Online
Status:	In Press
Schools:	Schools > Medicine
Publisher:	Oxford University Press (OUP)
ISSN:	0307-6938
Date of First Compliant Deposit:	23 March 2026
Date of Acceptance:	8 March 2026
Last Modified:	23 Mar 2026 12:00
URI:	https://orca.cardiff.ac.uk/id/eprint/185949

Actions (repository staff only)

Edit Item